Skip to main content
Premium Trial:

Request an Annual Quote

Soren Tulstrup, Jim Meade, Victor Ambros

Santaris Pharma said this week that Soren Tulstrup has been named as the company’s new president and CEO, effective July 1.
He will replace current President and CEO Keith McCullagh, who is retiring but will remain on the company’s board.
Tulstrup previously served as vice president of global health at Merck. Before that, he served as managing director of Merck subsidiary Merck, Sharp, & Dohme Ireland. He has also held various positions at Sandoz and Abbott Laboratories.
He has an MS in economics from Copenhagen Business School and an MBA from the JL Kellogg Graduate School of Management at Northwestern University.

Lentiviral vector firm Lentigen has named Jim Meade as vice president of corporate development.
Meade will be responsible for managing partnerships, stakeholder relations, product and intellectual property portfolios, contract negotiations, and other key aspects of corporate development, Lentigen said.
He previously served as vice president of business development at Avalon Pharmaceuticals. He holds a PhD in molecular biology from the University of Texas.

Victor Ambros, a researcher at the University of Massachusetts Medical School and microRNA pioneer, has joined RXi Pharmaceuticals’ scientific advisory board.
In 1993, Ambros first published the discovery of the first miRNA and reported how the small RNA regulated gene translation in C. elegans “via an antisense RNA-RNA interaction.”

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.